Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shock.

European journal of heart failure·2019

Same author

The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis.

Cardiorenal medicine·2019

Same author

The Promise of next generation sequencing micro RNA for the discovery of new targets in contrast induced acute kidney injury.

Annals of translational medicine·2019

Same author

Doppler-Derived Renal Venous Stasis Index in the Prognosis of Right Heart Failure.

Journal of the American Heart Association·2019

Same author

Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.

Cardiorenal medicine·2019

Same author

Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization - a Review.

Reviews in cardiovascular medicine·2019

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

Coronary artery disease.

Peter A McCullough¹

¹Department of Medicine, Division of Nutrition and Preventive Medicine, William Beaumont Hospital, Royal Oak, Michigan 48073, USA. pmccullough@beaumont.edu

Clinical Journal of the American Society of Nephrology : CJASN

|August 19, 2007

Summary

This summary is machine-generated.

Coronary heart disease (CHD) is a leading cause of death. This review examines CHD management in end-stage renal disease (ESRD) patients, highlighting different revascularization strategies for stable disease versus acute coronary syndromes.

More Related Videos

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

Related Experiment Videos

Last Updated: Jul 13, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

Area of Science:

Cardiology and Nephrology
Cardiovascular Disease in Chronic Kidney Disease

Background:

Coronary heart disease (CHD) is the primary cause of mortality in both the general population and patients with end-stage renal disease (ESRD).
Established principles of cardiovascular risk assessment and management are applicable to ESRD patients, though unique considerations exist.
Noninvasive coronary artery imaging advancements aid in the early detection of subclinical CHD.

Purpose of the Study:

To explore clinical issues surrounding coronary artery disease (CAD) in patients with ESRD.
To discuss the distinct risk-benefit profiles of coronary revascularization strategies in the ESRD population.
To review optimal management approaches for stable CAD and acute coronary syndromes (ACS) in ESRD.

Main Methods:

Review of current literature and clinical guidelines regarding CHD in ESRD.
Analysis of outcomes associated with different revascularization techniques (coronary artery bypass grafting vs. percutaneous coronary intervention).
Exploration of risk factors and management principles specific to ESRD patients with CAD.

Main Results:

Coronary artery bypass surgery is often favored for stable ESRD patients with multivessel CAD, despite inherent risks like stroke and infection.
Percutaneous coronary intervention on the target vessel demonstrates the most favorable outcomes for ESRD patients experiencing acute coronary syndromes.
Medical management aims to modify disease progression and alleviate angina symptoms.

Conclusions:

Management of coronary artery disease in ESRD requires careful consideration of patient-specific factors and procedural risks.
Revascularization strategies must be tailored based on disease presentation (stable vs. acute) to optimize outcomes in ESRD.
Further research is warranted to refine treatment protocols for this high-risk population.